Scientists test new shot to stop deadly ebola strain
NCT ID NCT06803342
Summary
This study is testing a new vaccine designed to protect against the Sudan strain of the Ebola virus. It will involve 200 healthy adults, who will receive either the vaccine or a placebo shot. The main goals are to see if the vaccine is safe and if it triggers a strong immune response that could protect against the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA SUDAN VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Optimal Research; LLC
Melbourne, Florida, 32934, United States
-
Synexus Clinical Research US, Inc.
Phoenix, Arizona, 85020, United States
-
Synexus Clinical Research US, Inc.
Chicago, Illinois, 60602, United States
-
Synexus Clinical Research US, Inc.
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.